The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.
Open accessAbstract
Both EGF and insulin, or IGF, stimulate the growth of many cell types by activating receptors that contain tyrosine kinase activities. A monoclonal antibody (mAb 225) against the EGF receptor produced in this laboratory has been shown to competitively inhibit EGF binding and block activation of receptor tyrosine kinase. Here we report that a human colorectal carcinoma cell line, DiFi, which expresses high levels of EGF receptors on plasma membranes, can be induced to undergo G1 cell cycle arrest and programmed cell death (apoptosis) when cultured with mAb 225 at concentrations that saturate EGF receptors. Addition of IGF-1 or high concentrations of insulin can delay apoptosis induced by mAb 225, while the G1 arrest cannot be reversed by either IGF-1 or insulin. Insulin/IGF-1 cannot activate EGF receptor tyrosine kinase that has been inhibited by mAb 225. Moreover, an mAb against the IGF-1 receptor, which has little direct effect on DiFi cell growth, can block the capacity of insulin/IGF-1 to delay apoptosis induced by mAb 225, suggesting that the insulin/IGF-1-mediated delay of apoptosis is acting through the IGF-1 receptor. In contrast, insulin/IGF-1 cannot delay the apoptosis caused by the DNA damaging agent, cisplatin. The results indicate that EGF receptor activation is required both for cell cycle progression and for prevention of apoptosis in DiFi cells, and that a signal transduction pathway shared by receptors for insulin/IGF-1 and EGF may be involved in regulating apoptosis triggered by blockade of the EGF receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Cell Death: The Significance of Apoptosis
Wyllie, A. H., Kerr, J. F. R., & Currie, A. R. (1980) · International Review of Cytology · doi:10.1016/s0074-7696(08)62312-8 · Cited by 7,162
Rinderknecht, E., & Humbel, R. E. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40889-1 · Cited by 1,545
RECEPTORS FOR EPIDERMAL GROWTH FACTOR AND OTHER POLYPEPTIDE MITOGENS
Carpenter, G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004313 · Cited by 1,281
Insulin Stimulates the Phosphorylation of the 95,000-Dalton Subunit of Its Own Receptor
Kasuga, M., Karlsson, F. A., & Kahn, C. R. (1982) · Science · doi:10.1126/science.7031900 · Cited by 1,126
DeCaprio, J. A., Ludlow, J. W., Lynch, D., Furukawa, Y., Griffin, J., Piwnica-Worms, H., Huang, C.-M., & Livingston, D. M. (1989) · Cell · doi:10.1016/0092-8674(89)90507-2 · Cited by 897
Kawamoto, T., Sato, J. D., Le, A., Polikoff, J., Sato, G. H., & Mendelsohn, J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.5.1337 · Cited by 791
Self-citationActivation of Programmed Cell Death in the Rat Ventral Prostate after Castration*
KYPRIANOU, N., & ISAACS, J. T. (1988) · Endocrinology · doi:10.1210/endo-122-2-552 · Cited by 720
Neal, D., Bennett, M., Hall, R., Marsh, C., Abel, P., Sainsbury, J. R. C., & Harris, A. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91386-8 · Cited by 604
Ludlow, J. W., DeCaprio, J. A., Huang, C.-M., Lee, W.-H., Paucha, E., & Livingston, D. M. (1989) · Cell · doi:10.1016/0092-8674(89)90983-5 · Cited by 494
Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.
Kyprianou, N., English, H. F., & Isaacs, J. T. (1990) · PubMed · Cited by 478
Expression of epidermal growth factor receptors in human brain tumors.
Libermann, T. A., Razon, N., Bartal, A. D., Yarden, Y., Schlessinger, J., & Soreq, H. (1984) · PubMed · Cited by 473
Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.
Sato, J. D., Kawamoto, T., Le, A. D., Mendelsohn, J. M., Polikoff, J., & SATO, G. H. (1983) · PubMed · Cited by 458
Self-citationGill, G. N., Kawamoto, T., Cochet, C., Le, A., Sato, J. D., Masui, H., McLeod, C., & Mendelsohn, J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42857-2 · Cited by 455
Self-citationMasui, H., Kawamoto, T., Sato, J. D., Wolf, B., Sato, G., & Mendelsohn, J. (1984) · Journal of Urology · doi:10.1016/s0022-5347(17)50005-1 · Cited by 446
Self-citationKyprianou, N., & Isaacs, J. T. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-10-1515 · Cited by 410
Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance.
Andrews, P. A., & Howell, S. B. (1990) · PubMed · Cited by 397
Somatomedin-C stimulates the phosphorylation of the beta-subunit of its own receptor.
Jacobs, S., Kull, F. C., Earp, H. S., Svoboda, M. E., Van Wyk, J. J., & Cuatrecasas, P. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44530-3 · Cited by 393
Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells
Gill, G. N., & Lazar, C. S. (1981) · Nature · doi:10.1038/293305a0 · Cited by 376
A monoclonal antibody to the human epidermal growth factor receptor
Waterfield, M. D., Mayes, E. L. V., Stroobant, P., Bennet, P. L. P., Young, S., Goodfellow, P. N., Banting, G. S., & Ozanne, B. (1982) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240200207 · Cited by 338
Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking.
Kasuga, M., Van Obberghen, E., Nissley, S. P., & Rechler, M. M. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69196-9 · Cited by 333
Epidermal growth factor receptors in non-small cell lung cancer
Veale, D., Ashcroft, T., Marsh, C., Gibson, G., & Harris, A. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.104 · Cited by 327
Over‐expression of the EGF receptor is a hallmark of squamous cell carcinomas
Ozanne, B., Richards, C. S., Hendler, F., Burns, D., & Gusterson, B. (1986) · The Journal of Pathology · doi:10.1002/path.1711490104 · Cited by 322
Fan, Z., Lu, Y., Wu, X., & Mendelsohn, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47026-3 · Cited by 283
Self-citationMasui, H., Kawamoto, T., Sato, J. D., Wolf, B., SATO, G. H., & Mendelsohn, J. (1984) · PubMed · Cited by 254
Self-citationApoptosis Biochemical events and relevance to cancer chemotherapy
Sen, S., & D'Incalci, M. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80914-3 · Cited by 236
Sainsbury, J. R., Malcolm, A. J., Appleton, D. R., Farndon, J. R., & Harris, A. L. (1985) · Journal of Clinical Pathology · doi:10.1136/jcp.38.11.1225 · Cited by 226
Hofer, D. R., Sherwood, E. R., Bromberg, W. D., Mendelsohn, J. M., Lee, C., & Kozlowski, J. M. (1991) · PubMed · Cited by 167
Self-citationArteaga, C. L., Coronado, E. B., & Osborne, C. K. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-11-1064 · Cited by 136
van de Vijver, M. J., Kumar, R., & Mendelsohn, J. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89475-7 · Cited by 122
Self-citationGrowth regulation of human renal carcinoma cells: role of transforming growth factor alpha.
Atlas, I., Mendelsohn, J., Baselga, J. M., Fair, W. R., Masui, H., & Kumar, R. (1992) · PubMed · Cited by 105
Self-citationMasui, H., Moroyama, T., & Mendelsohn, J. M. (1986) · PubMed · Cited by 103
Self-citationGross, M. E., Zorbas, M. A., Danels, Y. J., García, R., Gallick, G. E., Olivé, M., Brattain, M. G., Boman, B. M., & Yeoman, L. C. (1991) · PubMed · Cited by 94
Stampfer, M. R., Pan, C., Hosoda, J., Bartholomew, J., Mendelsohn, J. M., & Yaswen, P. (1993) · Experimental Cell Research · doi:10.1006/excr.1993.1236 · Cited by 79
Self-citationKarnes, W. E., Walsh, J. H., Wu, S. V., Kim, R. S., Martin, M. G., Wong, H. C., Mendelsohn, J. M., Park, J.-G., & Cuttitta, F. F. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90093-e · Cited by 71
Self-citationEpidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies.
Mendelsohn, J. M. (1992) · PubMed · Cited by 64
Self-citationKaplan, O., JAROSZEWSKI, J. W., Faustino, P. J., Zugmaier, G., Ennis, B. W., Lippman, M. E., & Cohen, J. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77397-3 · Cited by 58
Girault, J., Chamak, B., Bertuzzi, G., Tixier, H., Wang, J. K. T., Pang, D. T., & Greengard, P. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09751.x · Cited by 22
Cited by
Saltz, L. B., Meropol, N. J., Loehrer, P. J., Needle, M. N., Kopit, J., & Mayer, R. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.182 · Cited by 1,694
Review of epidermal growth factor receptor biology
Herbst, R. S. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.11.041 · Cited by 1,390
The EGF receptor family as targets for cancer therapy
Mendelsohn, J., & Baselga, J. (2000) · Oncogene · doi:10.1038/sj.onc.1204082 · Cited by 1,340
Self-citationStatus of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer
Mendelsohn, J., & Baselga, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.504 · Cited by 1,255
Self-citationBindingDB (2025) · PubMed · doi:10.7270/q2dr317m · Cited by 843
Metadata
- Authors
- Wu, X., Fan, Z., Masui, H., Rosen, N., & Mendelsohn, J.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-04-01
- Volume
- 95
- Issue
- 4
- Pages
- 1897-1905
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2038882649
- Cited by
- 381
- References
- 38
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.